Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05388123
Title Low Dose Vemurafenib and Rituximab in Hairy Cell Leukemia
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Scripps Health

hairy cell leukemia


Rituximab + Vemurafenib

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST